CENTOMD
DEAD

Serial Number

79158159

Owner

Centogene AG

Attorney

Angela P. Doughty

Filing Date

Jul 29, 2014

Add to watchlist:

No watchlists yet
View on USPTO

CENTOMD Trademark

Serial Number: 79158159 • Registration: 4995243

CENTOMD is a trademark filed by Centogene AG on July 29, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Centogene AG (16 trademarks)

Am Strande 7
18055 Rostock , DE

Entity Type: 09

Centogene GmbH (21 trademarks)

Am Strande 7
Rostock 18055 , DE

Entity Type: 99

Trademark Details

Filing Date

July 29, 2014

Registration Date

July 12, 2016

Published for Opposition

April 26, 2016

Cancellation Date

July 29, 2024

Goods & Services

Scientific, surveying, weighing, measuring and checking apparatus and instruments, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, DNA fragmentation and capture devices, thermal cycler, and thermal blocks for incubations all to determine the structure, composition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genome, to determine structure, composition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratories, namely, scientific devices to determine DNA or RNA sequence, alterations, rearrangements, copy number variations, and deletions; devices to determine biochemical markers, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, and DNA fragmentation and capture devices all for scientific purposes; devices to prepare respective biological samples for acquiring measurements, namely, thermal cyclers, thermal blocks, magnetic beads, pipetting tips, microcentrifuge tubes, and 96-well microplates; pre-recorded compact discs, DVDs, downloadable audio and video digital recordings, and digital video discs, all featuring clinical phenotypic, genetic molecular and demographic information; computers; computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments

Pharmaceutical preparations for hereditary diseases, metabolic diseases, oncological diseases, complex multigenic diseases and veterinary preparations for hereditary diseases, metabolic diseases, oncological diseases, complex multigenic diseases; diagnostic preparations for medical or veterinary purposes, namely, for detecting hereditary diseases via DNA sequencing or detecting other genetic lesions especially on multiple genes or the whole genomic coding region or the whole genome, for detecting DNA lesions in somatic samples, for biochemical analysis of biological samples, for analysis of predisposition for genetically driven disorders, prediction and monitoring of treatment response in a clinical laboratory all for medical or veterinary purposes; chemical preparations for analyses in laboratories, for medical or veterinary purposes, namely, nucleic acid and chemical reagents; biological preparations for medical purposes, namely, for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases

Compilation and systematic ordering of data in a computer database; computerised file management especially for data coming from DNA analysis from multiple genes or the genomic coding region or the whole genome

Medical services, in particular medical analysis in connection with the treatment of individuals; providing information in the fields of medicine, veterinary medicine and pharmaceuticals; health centers, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; medical clinics; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases; medical laboratory services for the analysis of samples taken from patients, namely, medical testing of blood, tissue, saliva, urine, and hair follicle

Scientific and technological services, namely, genetic and biochemical analytical testing for scientific research purposes and new product research and design relating thereto; industrial analysis and research services in the field of genetics and in the field of pharmaceutical development; scientific research for medical purposes in the field of hereditary diseases, oncology, and complex genetics related diseases; design and development of computer hardware and computer software that support the processing and analysis of complex genomic data; medical research laboratory services

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 21, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 21, 2025 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 23, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 30, 2023 INTS
INVALIDATION PROCESSED
Sep 30, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 27, 2023 INTR
CANCELLED SECTION 71
Jan 27, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 12, 2021 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 18, 2020 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 26, 2018 ADCH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 15, 2016 OPNX
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 12, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 12, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 17, 2016 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2016 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 1, 2016 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 26, 2016 NPUB
PUBLISHED FOR OPPOSITION
Apr 26, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 6, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 6, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 18, 2016 PREV
ASSIGNED TO LIE
Mar 16, 2016 ALIE
EXPARTE APPEAL TERMINATED
Mar 15, 2016 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 23, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 23, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 23, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 23, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2016 CRFA
ASSIGNED TO LIE
Feb 5, 2016 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 27, 2016 ERFR
EX PARTE APPEAL-INSTITUTED
Jan 27, 2016 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 27, 2016 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 27, 2016 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 28, 2015 GNFN
FINAL REFUSAL E-MAILED
Jul 28, 2015 GNFR
FINAL REFUSAL WRITTEN
Jul 28, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2015 TROA
REFUSAL PROCESSED BY IB
Jan 31, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 13, 2015 RFCS
REFUSAL PROCESSED BY MPU
Jan 13, 2015 RFRR
APPLICATION FILING RECEIPT MAILED
Jan 13, 2015 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 12, 2015 RFCR
NON-FINAL ACTION WRITTEN
Jan 11, 2015 CNRT
ASSIGNED TO EXAMINER
Jan 7, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2015 REPR